SCHEMBL24511005

SCHEMBL24511005

CNC(Cc1csc2ccccc12)C(=O)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.54
MMP9 P14780 1/20 0.54
MMP8 P22894 1/20 0.54
CYP2A6 P11509 2/20 0.49
CTSL P07711 1/20 0.48
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
TACR1 P25103 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
TP53 P04637 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
OPRM1 P35372 2/20 0.44
OPRD1 P41143 2/20 0.44
OPRK1 P41145 2/20 0.44
F10 P00742 2/20 0.44
TAAR1 Q96RJ0 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
POLB P06746 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009997 0.88 MMP2 (0.50) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL737926 0.88 MMP2 (0.50) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL16171971 0.88 MMP2 (0.50) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL14048310 0.87 MMP2 (0.52) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL12727418 0.87 MMP2 (0.52) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL20976930 0.87 MMP2 (0.52) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL805209 0.87 MMP2 (0.52) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL16203423 0.87 MMP2 (0.52) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL22679775 0.86 MMP2 (0.49) MMP2MMP9MMP8CYP2A6CTSL
SCHEMBL19203659 0.86 MMP2 (0.49) MMP2MMP9MMP8CYP2A6CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022123462-A1 RADIOLABELLED PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2022-06-16 WO disclosed